| Name | Title | Contact Details |
|---|
Using technology based on a fundamental scientific shift in material science, Xtalic is the trusted advisor and provider of breakthrough material solutions for market leaders with mission-critical problems. Founded by the head of the Department of Material Science and Engineering at the Massachusetts Institute of Technology, Xtalic has commercialized products with 30 leading electronics firms and continues to leverage its proprietary toolkit to design and patent stable nanostructured materials. Xtalics Dynamic Nanostructure Control® process supercharges relatively benign and widely available materials to break through customers most demanding requirements for hardness, strength, corrosion resistance, and durability. Customers turn to Xtalic when existing material solutions limit their ability to unlock the next level of product performance and features while maintaining their safety, price, and environmental goals.
Indian Creek Nature Ctr is a Cedar Rapids, IA-based company in the Business Services sector.
American Civil Liberties Union, Wisconsin is a Milwaukee, WI-based company in the Business Services sector.
Bulletproof Solutions is a Fredericton, NB-based company in the Business Services sector.
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.